...
机译:Patient Characteristics and Treatment Patterns among Medicare Beneficiaries Initiating PCSK9 Inhibitor Therapy
Tufts Med Ctr, Ctr Evaluat Value & Risk Hlth, Inst Clin Res & Hlth Policy Studies, 800 Washington;
Amgen Inc, Global Hlth Econ, Thousand Oaks, CA 91320 USA;
PCSK9i; LDL-C; Medicare beneficiaries; Lipid-lowering therapy; ASCVD;